HAV |
HBV |
HCV |
HDV |
HEV | |
modę oftransmis-sion |
fecal orał |
sexual contact, bloodto blood, perinatal |
sexual contact, bloodto blood, perinatal |
can cause infection only inthe presence of HBV, transmitted similarto HBV |
fecal orał |
Infectious-ness |
two weeks before onset of illness, not infectious after first week of jaundice |
before symptoms appear and for 4-6 months after acute illness. May be chronic carriers who are always infectious to others. |
1-2 weeks before symptoms appear, throughoutclinical course. Indefmitely in chronic carriers |
throughoutall phases of active infection |
not known, probably similarto HAV |
Lab tests |
Anti-HAV Ig M (current infection), Anti-HAV IgG (past resolved infection) |
HbsAg (current or chronic inf.), HBeAg (marker for incr.activity), Anti-HBc (marker for inf. at some time), AntiHBe (marker for decr. inf.), AntiHBs (marker for immunity, produced in response to vaccine) |
Anti-HCV (marker for infection) |
AntiHDV IgM (current inf.) Anti HDV IgG (past infection) |
serological tests under development |
Remarks |
complications rare, importance ofgood handwashi ng |
up to 10% become chronic carriers, and at risk forcirrhosis, liver cancer |
50% chronic carriers, at risk forcirrhosis, chronic liver disease, cancer |
chronic carriers of HBV at risk throughout carrierstate |
few cases seen in US, most in Asia, Africa and Mexico |
47